We are using cookies This website uses cookies in order to offer you the most relevant information. By browsing this website, you accept these cookies.
Cellular immune responses to intracutaneous recall antigens were reduced during treatment and returned to pretreatment conditions after withdrawal.
2
Tetanus booster vaccine, pneumococcal vaccine, and intracutaneous skin tests were administered to further evaluate humoral and cellular immune responses.
3
These results demonstrate that partial prophylaxis against papillomavirus-induced disease can be achieved by intracutaneous vaccination with a recombinant plasmid encoding the papillomavirus.
4
Results: Three out of four patients had a positive reaction to an intracutaneous test with SDH, but no reaction to the additive sodium succinate.
5
The LAMP and real-time PCR assays were both able to detect intracutaneous- and cohabitation-infection samples, with a concordance of 97.83%.